Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus.
about
Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiologyAddition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity.Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzeesThe major attenuating mutations of the respiratory syncytial virus vaccine candidate cpts530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature-sensitive alteration in mRNA terminationRecombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneAlternate immunoprophylactic and biologic techniques in the control of viral respiratory tract diseasesRespiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trialsGeneration of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus.The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein.Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse geneticsComparison of enzyme-linked immunosorbent assay and neutralization techniques for measurement of antibody to respiratory syncytial virus: implications for parenteral immunization with live virus vaccineViral and host factors in human respiratory syncytial virus pathogenesis.Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.Live-attenuated respiratory syncytial virus vaccines.Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in childrenTargeting RSV with vaccines and small molecule drugs.T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice.Serodiagnosis of respiratory synctial virus infections in infants and young children by the immunoperoxidse technique.Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV.Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs.The local antibody response to R.S. virus infection in the respiratory tract.Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.
P2860
Q21133803-DA501C3C-BF65-4C84-9709-BF47F264C44AQ33640019-C3845630-FF38-479E-A89A-BD91BE7B76E5Q33782914-5D826510-B11B-4AEE-BF59-9CF1A2F3F769Q33814574-2C98A563-2D7E-44C1-8E0A-D2D00AB00034Q33840469-F7A22087-5D08-4BA5-88CD-0E0AB1F11B4FQ34151865-25159BF0-E568-49EF-8B2E-9EE9ABAEF888Q34157386-3CE60C49-89EA-4A60-AB21-6C2672A9A050Q34328895-86F2DB82-096C-43E9-9633-676041D6DD1AQ34584485-BC66D980-13D6-4241-8E56-12F61EE80462Q35761061-15165337-03D5-4463-A889-BB2FF17DB164Q35872191-F562987D-DE4B-4176-B592-54A339D52BA2Q35889627-4C55F989-622C-4649-8940-6E4090F83898Q36276526-F130C6A6-AFED-4477-BE5B-46AFC88C68BDQ36329105-9DECA3D7-9CDB-4C9D-99EC-DDCAC23817F1Q36483836-2D183CEA-AA9E-4876-A0E9-0533A8DFA838Q36684360-41E175D7-B872-412C-98CE-692697ABB564Q36692801-B098A698-59F0-43D5-A1AD-492FAFAE9453Q37125280-C1CC399F-6DEB-45A4-AEA2-75E7CB5A0CFBQ37328584-5A7872AA-3DF9-490D-A9B7-DC9901DF7B9AQ37366590-F6A2699E-A672-4121-82F0-1C13307AC60CQ40229640-6774E87E-A15D-444A-9A69-BC56C386CA98Q40883566-E0246F9D-44C6-4B6E-871B-2ED404802034Q41827961-A4597B6A-A958-42CE-9D33-01AB45D6E1BEQ42790832-139531EF-4712-448A-A8BC-4208E0B5D09DQ47555408-54A3F65E-D60C-42E1-AEF1-E12FB3AE1B5D
P2860
Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus.
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh-hant
name
Clinical and immunological res ...... d respiratory syncytial virus.
@en
Clinical and immunological res ...... d respiratory syncytial virus.
@nl
type
label
Clinical and immunological res ...... d respiratory syncytial virus.
@en
Clinical and immunological res ...... d respiratory syncytial virus.
@nl
prefLabel
Clinical and immunological res ...... d respiratory syncytial virus.
@en
Clinical and immunological res ...... d respiratory syncytial virus.
@nl
P2093
P1433
P1476
Clinical and immunological res ...... d respiratory syncytial virus.
@en
P2093
Arrobio JO
Chanock RM
Parrott RH
P304
P407
P577
1971-11-01T00:00:00Z